| 1 to 1 of 1 Ontology terms |
|
| Ontology term |
Gene (Gene Symbol) |
Gene Name |
Pathways |
Associated Diseases |
| Feeding behavior |
| GCG |
Glucagon |
|
Diabetes mellitus type 2
|
| NPY |
Neuropeptide Y |
Adipocytokine signaling pathway |
Epilepsy, Essential hypertension, Cardiovascular diseases, Major depression, Alzheimers disease, Vitiligo, Stress disorders posttraumatic, Diabetes mellitus, Delirium tremens, Autoimmunity, Schizophrenia, Fibromyalgia, Renal disease, Diabetes mellitus insulin-dependent, Osteoporosis, Seizures febrile, Von hippel-lindau disease, Cerebral ischemia, Cancer (breast carcinoma), Respiratory failure, Ascites, Gastrointestinal diseases, Cancer (carcinoma), Inflammation, Hypertrophy, Cancer (adenoma), Celiac disease, Low-grade chronic inflammation, Insulin resistance, Endothelial dysfunction, Atherosclerosis, Obesity, Anorexia nervosa, Bulimia nervosa, Neuroendocrine tumors
|
| PYY |
Peptide YY |
|
Pancreatic islet adaptation to insulin resistance, Low-grade chronic inflammation, Endothelial dysfunction, Atherosclerosis, Obesity
|
| Positive regulation of positive chemotaxis |
| F3 |
Coagulation factor III (thromboplastin, tissue factor) |
Complement and coagulation cascades |
Atherothrombosis
|
| VEGFA |
Vascular endothelial growth factor A |
|
Polycystic ovary syndrome (PCOS), Ovarian hyperstimulation syndrome (OHSS), Cardiovascular diseases
|
| Negative regulation of circadian sleep/wake cycle, REM sleep |
| CRH |
Corticotropin releasing hormone |
Long-term depression |
Acth deficiency, Major depression, Anxiety disorders, Stress disorders posttraumatic, Anorexia nervosa, Preterm delivery, Psychiatric disorder, Alcoholism, Preeclampsia, Panic disorder, Endocrine disorder, Obesity, Labor premature, Fibromyalgia, Hyperandrogenism, Rheumatoid arthritis, Dementia multi-infarct, Epilepsy frontal lobe, Cancer (choriocarcinoma), Gastrointestinal diseases, Sheehan syndrome, Virilization, Alzheimers disease, Polycystic ovary syndrome (PCOS)
|
| GHRL |
Ghrelin/obestatin prepropeptide |
|
Obesity, Prader-willi syndrome, Bulimia nervosa, Acromegaly, Functional dyspepsia, Endocrine effects, Hypercortisolism, Cancer (adenoma), Hypogonadism, Inflammation, Anovulation, Hyperthyroidism, Cardiovascular diseases, Hypothyroidism, Polycystic ovaries, Diabetes mellitus, Hypopituitarism, Wasting syndrome, Gastrointestinal diseases, Alcoholism, Arthritis, Celiac disease, Epilepsy, Cancer (carcinoma), Hypertrophy, Anorexia nervosa, Polycystic ovary syndrome (PCOS), Insulin resistance, Hyperandrogenism, Endothelial dysfunction, Atherosclerosis
|
| Induction of positive chemotaxis |
| VEGFA |
Vascular endothelial growth factor A |
|
Polycystic ovary syndrome (PCOS), Ovarian hyperstimulation syndrome (OHSS), Cardiovascular diseases
|
| Positive regulation of mast cell chemotaxis |
| VEGFA |
Vascular endothelial growth factor A |
|
Polycystic ovary syndrome (PCOS), Ovarian hyperstimulation syndrome (OHSS), Cardiovascular diseases
|
| Eating behavior |
| CCK |
Cholecystokinin |
|
Panic disorder, Chronic pancreatitis, Functional dyspepsia, Anorexia nervosa, Hyperalgesia, Gastrointestinal diseases, Delirium tremens, Apeced, Schizophrenia, Celiac disease, Anxiety disorders, Diabetes mellitus, Psychotic, Alzheimers disease
|
| Behavior |
| NPY |
Neuropeptide Y |
Adipocytokine signaling pathway |
Epilepsy, Essential hypertension, Cardiovascular diseases, Major depression, Alzheimers disease, Vitiligo, Stress disorders posttraumatic, Diabetes mellitus, Delirium tremens, Autoimmunity, Schizophrenia, Fibromyalgia, Renal disease, Diabetes mellitus insulin-dependent, Osteoporosis, Seizures febrile, Von hippel-lindau disease, Cerebral ischemia, Cancer (breast carcinoma), Respiratory failure, Ascites, Gastrointestinal diseases, Cancer (carcinoma), Inflammation, Hypertrophy, Cancer (adenoma), Celiac disease, Low-grade chronic inflammation, Insulin resistance, Endothelial dysfunction, Atherosclerosis, Obesity, Anorexia nervosa, Bulimia nervosa, Neuroendocrine tumors
|
| Mating behavior |
| MTNR1A |
Melatonin receptor 1A |
Neuroactive ligand-receptor interaction |
Alzheimers disease, Polycystic ovary syndrome (PCOS), Insulin resistance
|
| Positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
| VEGFA |
Vascular endothelial growth factor A |
|
Polycystic ovary syndrome (PCOS), Ovarian hyperstimulation syndrome (OHSS), Cardiovascular diseases
|
| Negative regulation of natural killer cell chemotaxis |
| CCL2 |
Chemokine (C-C motif) ligand 2 |
Cytokine-cytokine receptor interaction, Chemokine signaling pathway, NOD-like receptor signaling pathway, Chagas disease (American trypanosomiasis), Malaria, Influenza A, Rheumatoid arthritis |
Vascular damage and cardiovascular disease, Polycystic ovary syndrome (PCOS), Obesity, Low-grade chronic inflammation, Hyperinsulinism, Hyperglycemia, Hyperandrogenism, Chronic low-level inflammation, Atherogenesis
|
|
|
|
|
